Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Proxy Solicitation & Information Statement 2025

Oct 2, 2025

65715_rns_2025-10-02_0531b54a-d211-40c0-af70-5568355f314e.pdf

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

Filed by the Registrant  Filed by a Party other than the Registrant 

Check the appropriate box:

  • Preliminary Proxy Statement

  • Definitive Proxy Statement

  • Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

  • Definitive Additional Materials

  • Soliciting Material Pursuant to § 240.14A-12

==> picture [166 x 35] intentionally omitted <==

(Name of Registrant as Specified in its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

Payment of Filing Fee (Check all boxes that apply):

  • No fee required.

  • Fee paid previously with preliminary materials.

  • Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

Your Vote Counts!

RESMED INC.

2025 Annual Meeting Date: November 19, 2025 Time: 3:00 p.m. (US Pacific Time) November 20, 2025 Time: 10:00 a.m. (Australian Eastern Time) Live webcast: Meeting live via the internet-please visit www.virtualshareholdermeeting.com/RMD2025

RESMED INC. 9001 SPECTRUM CENTER BLVD. SAN DIEGO, CA 92123 ATTN: SALLI SCHWARTZ

==> picture [207 x 158] intentionally omitted <==

==> picture [50 x 6] intentionally omitted <==

----- Start of picture text -----

V79601-P37693
----- End of picture text -----

Important notice regarding the availability of proxy materials for the stockholder meeting to be held on November 19, 2025 (US Time) / November 20, 2025 (Australian Time).

You invested in RESMED INC. and it’s time to vote!

You have the right to vote on proposals being presented at the Annual Meeting.

Get informed before you vote

View the Notice, Proxy Statement, and Form 10-K online at www.ProxyVote.com, OR you can receive a free paper or email copy of the materials. If you would like to request a copy of the materials for this and/or future stockholder meetings, you may (1) visit http://www.ProxyVote.com, (2) call 1-800-579-1639, or (3) send an email to [email protected], by November 5, 2025. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.

For complete information and to vote, visit www.ProxyVote.com Control # Smartphone users Vote Virtually at the Meeting* Point your camera here and November 19, 2025 at 3:00 p.m. (US Pacific Time) vote without entering a November 20, 2025 at 10:00 a.m. (Australian Eastern Time) control number Virtually at: www.virtualshareholdermeeting.com/RMD2025

==> picture [56 x 39] intentionally omitted <==

*Please check the meeting materials for any special requirements for meeting attendance.

Vote at www.ProxyVote.com

THIS IS NOT A VOTABLE BALLOT

This is an overview of the proposals being presented at the upcoming stockholder meeting. Please follow the instructions on the reverse side to vote these important matters.

Voting Items
Board
Recommends
Voting Items
Board
Recommends
1.
Elect 11 directors, each to serve until our 2026 annual meeting and until their successors are elected and qualified.
The nominees for election as directors at the 2025 annual meeting are:
1a. Carol Burt
For
1b. Christopher DelOrefice For
1c. Jan De Witte For
1d. Karen Drexler For
1e. Michael Farrell For
1f. Peter Farrell For
1g. Harjit Gill For
1h. John Hernandez For
1i.
Nicole Mowad-Nassar
For
1j.
DesneyTan
For
1k. Ronald Taylor For
2.
Ratify our selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending
June 30, 2026.
For
3.
Approve, on an advisorybasis, the compensationpaid to our named executive officers.
For
4.
Approve the amendment and restatement of our 2009 Incentive Award Plan.
For
5.
Approve the amendment and restatement of our 2018 Employee Stock Purchase Plan.
For

Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”.

V79602-P37693